Proteomic discovery of Max as a novel interacting partner of C/EBPα: A Myc/Max/Mad link

Leukemia

Volumn 20, Issue 12, 2006, Pages 2137-2146

  Zada, A A ^a   Pulikkan, J A ^a   Bararia, D ^a   Geletu, M ^a   Trivedi, A K ^a   Balkhi, M Y ^a   Hiddemann, W D ^b   Tenen, D G ^c   Behre, H M ^a   Behre, G ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CD11B ANTIGEN; CD15 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MAX PROTEIN; MYC PROTEIN; RETINOIC ACID; SHORT HAIRPIN RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; MASS SPECTROMETRY; MYELOID PROGENITOR CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; TRANSACTIVATION;

EID: 33751235604     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404438     Document Type: Article

References (34)

1. Scott LM, Civin CI, Rorth P, Friedman AD. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 1992; 80: 1725-1735.
2. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 1997; 94: 569-574.
3. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, Owens BM et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004; 21: 853-863.
4. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001; 27: 263-270.
5. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G et al. AML1-ETO downregulates the granulocytic differentiation factor C/ EBPalpha in t(8;21) myeloid leukemia. Nat Med 2001; 7: 444-451.
6. Rangatia J, Vangala RK, Treiber N, Zhang P, Radomska H, Tenen DG et al. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment. Mol Cell Biol 2002; 22: 8681-8694.
7. Reddy VA, Iwama A, Iotzova G, Schulz M, Elsasser A, Vangala RK et al. Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: Possible role in lineage commitment decisions. Blood 2002; 100: 483-490.
8. Porse BT, Pedersen TA, Xu X, Lindberg B, Wewer UM, Friis-Hansen L et al. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell 2001; 107: 247-258.
9. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. CCAAT/ enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 1996; 10: 804-815.
10. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ et al. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 2001; 8: 817-828.
11. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000; 16: 653-699.
12. Atchley WR, Fernandes AD. Sequence signatures and the probabilistic identification of proteins in the Myc-Max-Mad network. Proc Natl Acad Sci USA 2005; 102: 6401-6406.
13. Holzel M, Kohlhuber F, Schlosser I, Holzel D, Luscher B, Eick D. Myc/Max/ Mad regulate the frequency but not the duration of productive cell cycles. EMBO Rep 2001; 2: 1125-1132.
14. Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG et al. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 1995; 14: 5646-5659.
15. Nilsson JA, Maclean KH, Keller UB, Pendeville H, Baudino TA, Cleveland JL. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol 2004; 24: 1560-1569.
16. Blackwood EM, Luscher B, Kretzner L, Eisenman RN. The Myc:MAx protein complex and cell growth regulation. Cold Spring Harb Symp Quant Biol 1991; 56: 109-117.
17. Kato GJ, Lee WM, Chen LL, Dang CV. Max: Functional domains and interaction with c-Myc. Genes Dev 1992; 6: 81-92.
18. James L, Eisenman RN. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo. Proc Natl Acad Sci USA 2002; 99: 10429-10434.
19. Luscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 2001; 277: 1-14.
20. Kretzner L, Blackwood EM, Eisenman RN. Myc and Max proteins possess distinct transcriptional activities. Nature 1992; 359: 426-429.
21. Legraverend C, Antonson P, Flodby P, Xanthopoulos KG. High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors. Nucleic Acids Res 1993; 21: 1735-1742.
22. D'Alo' F, Johansen LM, Nelson EA, Radomska HS, Evans EK, Zhang P et al. The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells. Blood 2003; 102: 3163-3171.
23. Zada AA, Singh SM, Reddy VA, Elsasser A, Meisel A, Haferlach T et al. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation. Oncogene 2003; 22: 2296-2308.
24. Ayer AE, Eisenman RN. A switch from Myc:MAx to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 1993; 7: 2110-2119.
25. Kohlhuber F, Hermeking H, Graessmann A, Eick D. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts. J Biol Chem 1995; 270: 28797-28805.
26. Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR et al. c-Myc is a critical target for c/EBPalpha in granulopoiesis. Mol Cell Biol 2001; 21: 3789-3806.
27. Metcalf D, Lindeman GJ, Nicola NA. Analysis of hematopoiesis in max 41 transgenic mice that exhibit sustained elevations of blood granulocytes and monocytes. Blood 1995; 85: 2364-2370.
28. Liu H, Keefer JR, Wang QF, Friedman AD. Reciprocal effects of C/EBPalpha and PKCdelta on JunB expression and monocytic differentiation depend upon the C/EBPalpha basic region. Blood 2003; 101: 3885-3892.
29. Timchenko NA, Harris TE, Wilde M, Bilyeu TA, Burgess-Beusse BL, Finegold MJ et al. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol 1997; 17: 7353-7361.
30. Timchenko NA, Wilde M, Darlington GJ. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice. Mol Cell Biol 1999; 19: 2936-2945.
31. Schaufele F, Enwright III JF, Wang X, Teoh C, Srihari R, Erickson R et al. CCAAT/enhancer binding protein alpha assembles essential cooperating factors in common subnuclear domains. Mol Endocrinol 2001; 15: 1665-1676.
32. Timchenko N, Wilson DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M et al. Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol 1995; 15: 1192-1202.
33. Wang D, D'costa J, Civin CI, Friedman AD. C/EBP{alpha} directs monocytic commitment of primary myeloid progenitors. Blood 2006; 108: 1223-1229.
34. Peer Zada AA, Geletu HM, Pulikkan JA, Müller CT, Reddy VA, Christopeit M et al. Proteomic analysis of acute promyelocytic leukemia: PML-RARalpha leads to decreased phosphorylation of OP18 at Ser63. Proteomics 2006 (in press).